Chen, Han
Ji, Meng
Zhang, Yi
Xu, Yawei
Qiao, Lingjuan
Shen, Li
Ge, Junbo
Funding for this research was provided by:
Science and Technology Commission of Shanghai Municipality (15441900100)
Article History
Received: 12 December 2018
Accepted: 31 August 2019
First Online: 28 November 2019
Change Date: 27 December 2019
Change Type: Correction
Change Details: After publication of our article [1] we were notified that the word “References” was wrongly included in the title.
Ethics approval and consent to participate
: This clinical trial will be undertaken strictly according to the protocol and good clinical practice regulations. Informed consent will be obtained from all study participants. Central ethical approval has been received from the institutional ethical review board of Zhongshan Hospital (2018-58), and we will not begin recruiting at other centers in the trial until local ethical approval has been obtained.
: Our findings will be shared with participating hospitals, policy makers, and the academic community to promote the clinical management of uncontrolled hypertension in China.
: LQ is from CryoFocus MedTech, where the device and thechnique support of CyroFocus cryo-RDN catheter system were kindly provided. The authors declare that they have no competing interests.